Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney Hicks

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Current Radiopharmaceuticals|March 16, 2017
β -[<sup>18</sup>F]Fluoro Azomycin Arabinoside (β -[<sup>18</sup>F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 TumorsPiyush Kumar, Peter Roselt, Gerald Reischl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2020
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and ExperiencesJohannes Czernin, Stefano Fanti, Philipp T Meyer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
In vivo tracking of dendritic cells in patients with multiple myelomaH Miles Prince, Dominic M Wall, David Ritchie, et al.
Investigational New Drugs|August 7, 2019
Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanomaShahneen Sandhu, Catriona M McNeil, Patricia LoRusso, et al.
The Lancet. Haematology|July 1, 2022
[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trialAbby Douglas, Karin Thursky, Timothy Spelman, et al.
Neuroendocrinology|September 1, 2022
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide TherapyMinmin Li, David L Chan, Gonzalo Tapia Rico, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2009
The risk of exaggerated risk aversion-a life and death struggle for molecular imagingBengt Långström, Anders Grahnen, Per Hartvig Honoré, et al.
Nature Reviews. Endocrinology|December 14, 2023
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementDavid Taïeb, Svenja Nölting, Nancy D Perrier, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Current Radiopharmaceuticals|March 16, 2017
β -[<sup>18</sup>F]Fluoro Azomycin Arabinoside (β -[<sup>18</sup>F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 TumorsPiyush Kumar, Peter Roselt, Gerald Reischl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2020
Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and ExperiencesJohannes Czernin, Stefano Fanti, Philipp T Meyer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2008
In vivo tracking of dendritic cells in patients with multiple myelomaH Miles Prince, Dominic M Wall, David Ritchie, et al.
Investigational New Drugs|August 7, 2019
Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanomaShahneen Sandhu, Catriona M McNeil, Patricia LoRusso, et al.
The Lancet. Haematology|July 1, 2022
[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trialAbby Douglas, Karin Thursky, Timothy Spelman, et al.
Neuroendocrinology|September 1, 2022
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide TherapyMinmin Li, David L Chan, Gonzalo Tapia Rico, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2009
The risk of exaggerated risk aversion-a life and death struggle for molecular imagingBengt Långström, Anders Grahnen, Per Hartvig Honoré, et al.
Nature Reviews. Endocrinology|December 14, 2023
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statementDavid Taïeb, Svenja Nölting, Nancy D Perrier, et al.
Pageof 3